CV Shariat_AKH - Vienna OMI

More documents

Recommendations

Info

22. Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester R, Burger M, Cowan N, Böhle A, VanRhijn BW, Kaasinen E, Palou J, Shariat SF. European guidelines on upper tract urothelialcarcinomas: 2013 update. Eur Urol. 2013 Jun;63(6):1059-71. PMID: 2354095323. Kluth LA, Rink M, Shariat SF, Chun FK, Fisch M, Dahm P. Use and interpretation of the numberneeded to treat in urological practice.Urologe A. 2013 May;52(5):682-5. PMID: 2353220124. Bagrodia A, Kuehhas FE, Gayed BA, Wood CG, Raman JD, Kapur P, Derweesh IH, Bensalah K,Sagalowsky AI, Shariat SF, Lotan Y, Margulis V. Comparative analysis of oncologic outcomesof partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.Urology. 2013 May;81(5):972-8. PMID: 2352329225. Sammon J, Trinh VQ, Ravi P, Sukumar S, Gervais MK, Shariat SF, Larouche A, Tian Z, KimSP, Kowalczyk KJ, Hu JC, Menon M, Karakiewicz PI, Trinh QD, Sun M. Health care-associatedinfections after major cancer surgery: Temporal trends, patterns of care, and effect on mortality.Cancer. 2013 Mar 19. [Epub ahead of print] PMID: 2351247326. Dariane C, Le Cossec C, Drouin SJ, Wolff B, Granger B, Mozer P, Bitker MO, Shariat SF,Cussenot O, Rouprêt M.Comparison of oncologic outcomes after radical prostatectomy in mendiagnosed with prostate cancer with PSA levels below and above 4 ng/mL. World J Urol. 2013Apr 26. [Epub ahead of print] PMID: 2361947927. Rink M, Kluth LA, Shariat SF, Dahlem R, Fisch M, Dahm P. [Confidence intervals and p-valuesin urology: Interpretation and misinterpretation.] Urologe A. 2013 Mar 21. [Epub ahead of print]German. PMID: 235118528. Rink M, Kluth LA, Shariat SF, Chun FK, Fisch M, Dahm P. [Use of PubMed to improveevidence-based medicine in routine urological practice]. Urologe A. 2013 Mar;52(3):367-72.German. PMID: 2350379429. Sun M, Trinh QD, Bianchi M, Hansen J, Abdollah F, Tian Z, Shariat SF, Montorsi F, Perrotte P,Karakiewicz PI. Extent of lymphadenectomy does not improve the survival of patients with renalcell carcinoma and nodal metastases: biases associated with the handling of missing data. BJU Int.2013 Mar 12. [Epub ahead of print] PMID: 2349003130. Abdollah F, Gandaglia G, Thuret R, Schmitges J, Tian Z, Jeldres C, Passoni NM, Briganti A,Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI, Sun M. Incidence, survival and mortalityrates of stage-specific bladder cancer in United States: A trend analysis. Cancer Epidemiol. 2013Feb 25. [Epub ahead of print] PMID: 234854831. Cindolo L, Chiodini P, Brookman-May S, De Cobelli O, May M, Squillacciotti S, De Nunzio C,Tubaro A, Coman I, Feciche B, Truss M, Wirth MP, Dalpiaz O, Chromecki TF, Shariat SF,Sanchez-Chapado M, Del Carmen Santiago Martin M, Rocco B, Salzano L, Lotrecchiano G,Berardinelli F, Schips L. Assessing the accuracy and generalizability of the preoperative andpostoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentreEuropean and US study. BJU Int. 2013 Mar 7 [Epub ahead of print] PMID: 2347019932. Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, PychaA, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF. Impact ofhistological variants on oncological outcomes of patients with urothelial carcinoma of the bladdertreated with radical cystectomy. Eur J Cancer. 2013 Mar 2. [Epub ahead of print] PMID:2346612633. Rink M, Xylinas E, Trinh QD, Lotan Y, Margulis V, Raman JD, Fisch M, Lee RK, Chun FK,Abdennabi J, Seitz C, Pycha A, Zlotta AR, Karakiewicz PI, Babjuk M, Scherr DS, Shariat SF:Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes. BJU Int. 2013Mar 6. PMID: 2346508834. Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E, Novara G, Raman JD, Lotan Y,Weizer A, Roupret M, Pycha A, Scherr DS, Seitz C, Ficarra V, Trinh QD, Karakiewicz PI,Montorsi F, Zerbib M, Shariat SF: Impact of renal function on eligibility for chemotherapy andsurvival in patients who have undergone radical nephro-ureterectomy. BJU Int. 2013 Mar 6. [Epubahead of print] PMID: 2346497935. Trinh QD, Sun M, Kim SP, Sammon J, Kowalczyk KJ, Friedman AA, Sukumar S, Ravi P,Muhletaler F, Agarwal PK, Shariat SF, Hu JC, Menon M, Karakiewicz PI. The impact of hospitalvolume, residency, and fellowship training on perioperative outcomes after radical prostatectomy.Urol Oncol. 2013 Feb 28. PMID: 23453659www.vienna-omi.at 28.08.2013
36. May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Burger M, Gunia S,Feciche B, Wenzl V, Aziz A, Chun F, Becker A, Pahernik S, Simeone C, Longo N, Zucchi A,Antonelli A, Mirone V, Stief C, Novara G, Brookman-May S; Members of the CORONA- and theSATURN projects, and the Young Academic Urologists Renal Cancer Group. Impact of clinicaland histopathological parameters on disease-specific survival in patients with collecting duct renalcell carcinoma - Development of a disease-specific risk-model. J Urol. 2013 Feb 19. [Epub aheadof print] PMID: 2343494337. Bianchi M, Becker A, Abdollah F, Trinh QD, Hansen J, Tian Z, Shariat SF, Perrotte P,Karakiewicz PI, Sun M. Rates of open versus laparoscopic and partial versus radical nephrectomyfor T1a renal cell carcinoma: A population-based evaluation. Int J Urol. 2013 Feb 19. [Epub aheadof print] PMID: 2341892138. Sun M, Ravi P, Karakiewicz PI, Sukumar S, Sammon J, Bianchi M, Shariat SF, Jeong W, GhaniKR, Hansen J, Friedman A, Perrotte P, Peabody JO, Menon M, Trinh QD. Is there a relationshipbetween leapfrog volume thresholds and perioperative outcomes after radical cystectomy? UrolOncol. 2013 Feb 9. [Epub ahead of print] PMID: 2340316239. da Silva RD, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Chade D, Guglielmetti GB, Pycha A,Lotan Y, Karakiewicz PI, Sun M, Fajkovic H, Zerbib M, Scherr DS, Shariat SF: Impact of StatinUse on Oncological Outcomes of Patients with Urothelial Carcinoma of the Bladder Treated WithRadical Cystectomy. J Urol. 2013 Feb 7. [Epub ahead of print] PMID: 2339580240. Kluth LA, Xylinas E, Crivelli JJ, Passoni N, Comploj E, Pycha A, Chrystal J, Sun M,Karakiewicz PI, Gontero P, Lotan Y, Chun FK, Fisch M, Scherr DS, Shariat SF. Obesity isassociated with worse outcomes in patients with T1 high grade urothelial carcinoma of thebladder. J Urol. 2013 Jan 31. [Epub ahead of print] PMID: 2337670741. Larré S, Catto JW, Cookson MS, Messing EM, Shariat SF, Soloway MS, Svatek RS, Lotan Y,Zlotta AR, Grossman HB. Screening for bladder cancer: rationale, limitations, whom to target, andperspectives. Eur Urol. 2013 PMID: 2331303442. Hansen J, Rink M, Graefen M, Shariat S, Chun FK: Assays for Prostate Cancer: Changing theScreening Paradigm? Mol Diagn Ther. 2013 Jan 25. PMID:2335509843. Margulis V, Shariat SF, Rapoport Y, Rink M, Sjoberg DD, Tannir NM, Abel EJ, Culp SH,Tamboli P, Wood CG. Development of accurate models for individualized prediction of survivalafter cytoreductive nephrectomy for metastatic renal cell carcinoma. Eur Urol. 2012 PMID:2327368144. Xylinas E, Rink M, Margulis V, Faison T, Comploj E, Novara G, Raman JD, Lotan Y,Guillonneau B, Weizer A, Pycha A, Scherr DS, Seitz C, Sun M, Trinh QD, Karakiewicz PI,Montorsi F, Zerbib M, Gönen M, Shariat SF. Prediction of true nodal status in patients withpathological lymph node negative upper tract urothelial carcinoma at radicalnephroureterectomy. J Urol. 2012 Dec 14. PMID: 2325396045. Trinh QD, Sukumar S, Schmitges J, Bianchi M, Sun M, Shariat SF, Sammon JD, Jeldres C,Zorn KC, Perrotte P, Graefen M, Rogers CG, Peabody JO, Menon M, Karakiewicz PI: Effect ofnodal metastases on cancer-specific mortality after cytoreductive nephrectomy. Ann Surg Oncol.2012 Dec 23. PMID: 2326377946. Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y,Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF.Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated withradical cystectomy. Eur Urol. 2012 Nov 27 PMID: 23206854 the47. Najari BB, Rink M, Li PS, Karakiewicz PI, Scherr DS, Shabsigh R, Meryn S, Schlegel PN,Shariat SF. Sex disparities in cancer mortality: risks of being a man in the U.S. J Urol. 2012 Nov30. PMID: 2320642248. Kluth LA, Fajkovic H, Xylinas E, Crivelli JJ, Passoni N, Rouprêt M, Becker A, Comploj E,Pycha A, Holmang S, Gupta A, Lotan Y, Karakiewicz PI, Gontero P, Chun FK, Fisch M, ScherrDS, Shariat SF. Female gender is associated with higher risk of disease recurrence in patientswith primary T1 high-grade urothelial carcinoma of the bladder. World J Urol. 2012 Nov 30.PMID: 23196773www.vienna-omi.at 28.08.2013
Page 1 and 2: SHAHROKH F. SHARIAT, MDProfessor an
Page 3 and 4: E D U C A T I O N & M E D I C A L T
Page 5 and 6: • Glaxo SmithKline Scholar Award,
Page 7 and 8: May 29-June 3, 2010. J.Urol 183(4):
Page 9 and 10: • Leading Physician of the World
Page 11 and 12: Weill Cornell Medical Center, Princ
Page 13 and 14: Inventor: Shahrokh ShariatThe prese
Page 15 and 16: • Chair of Sessions - The Inaugur
Page 17 and 18: • Guest Editor of special issue o
Page 19 and 20: • Visiting Professor, Division of
Page 21 and 22: Ablative therapy for small renal co
Page 23 and 24: Bladder cancer: opportunities for i
Page 25: 7. Merseburger AS, Herrmann TR, Sha
Page 29 and 30: Results from of a Large Multicenter
Page 31 and 32: trends and disparities in the use o
Page 33 and 34: 112. Abdollah F, Sun M, Thuret R, J
Page 35 and 36: 139. Fajkovic H, Cha EK, Jeldres C,
Page 37 and 38: RK, Margulis V, Shariat SF: Tissue-
Page 39 and 40: 21869907190. Abdollah F, Sun M, Jel
Page 41 and 42: Montorsi F, Karakiewicz PI: The imp
Page 43 and 44: Fradet Y, Shariat SF. Prognostic ri
Page 45 and 46: 271. Shariat SF, Lotan Y, Vickers A
Page 47 and 48: 298. Shariat SF, Kattan MW, Vickers
Page 49 and 50: 324. Capitanio U, Isbarn H, Shariat
Page 51 and 52: 349. Margulis V, Shariat SF, Matin
Page 53 and 54: 378. Karakiewicz PI, Bhojani N, Cap
Page 55 and 56: 410. Shariat SF, Lamb DJ, Iyengar R
Page 57 and 58: 442. Chun FK, Briganti A, Gallina A
Page 59 and 60: cystectomy for primary nontransitio
Page 61 and 62: Slawin KM. Salvage radiotherapy for
Page 63 and 64: 535. Shariat SF, Desai S, Song W, K
Page 65 and 66: 21. SunM., Abdollah F., Schmitges J
Page 67 and 68: progression after radical prostatec
Page 69 and 70: Y., Karakiewicz P.: Assessement of
Page 71 and 72: 50. Shariat S., Karakiewicz P., Fra
Page 73 and 74: predictions in patients with adreno
Page 75 and 76: Schoenberg, G. E. Amiel, S. P. Lern
Page 77 and 78:
113. Claudio Jeldres, Maxime Crepel
Page 79 and 80:
(volume 183 issue 4 Page e227)134.
Page 81 and 82:
156. Ramy Youssef, Shahrokh Shariat
Page 83 and 84:
Localized .Sunday, May 15, 2011 Ame
Page 85 and 86:
Health Conference. 2-5 October 2011
Page 87 and 88:
urothelial carcinoma. Poster #155.
Page 89 and 90:
supplementation on the prevention o
Page 91 and 92:
for metastatic renal cell carcinoma
Page 93 and 94:
muscle-invasive urothelial carcinom
Page 95 and 96:
Shahrokh Shariat Prediction of intr
Page 97 and 98:
Terrone; Derya Tilki; Daniel Vergho
Page 99 and 100:
P.I.: Drs. Shahrokh Shariat and Dou
show all

CV Shariat_AKH - Vienna OMI

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?